https://www.tibsovopro.com/ 2026-10-09 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/request-a-visit 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/idh1-mutation 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/static/images/moa-slider-1.png A 3-panel diagram illustrating the mechanism of action of mutant IDH1. Panel 1 shows a myeloblast where increased 2-HG leads to DNA and histone hypermethylation. Panel 2 depicts how normal differentiation of myeloblasts is blocked. Panel 3 shows the resulting unchecked proliferation of undifferentiated myeloblasts. https://www.tibsovopro.com/access 2026-10-09 https://www.tibsovopro.com/static/images/bottle-of-tibsovo-ivosidenib-tablets.png TIBSOVO® (ivosidenib tablets) bottle with two pills. https://www.tibsovopro.com/static/images/servier-one-logo.svg ServierONE® logo. https://www.tibsovopro.com/aml 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/site-map 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/efficacy/newly-diagnosed-tibsovo-and-azacitidine 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/tibsovo-azacitidine-rates-of-cr-and-crh-graph-desktop.svg TIBSOVO + azacitidine vs placebo + azacitidine overall survival graph. https://www.tibsovopro.com/static/images/tibsovo-azacitidine-rates-of-cr-and-crh-graph-mobile.svg TIBSOVO + azacitidine vs placebo + azacitidine overall survival graph. https://www.tibsovopro.com/static/images/os-12-months.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/os-12-months-mobile.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/os-24-months.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/os-24-months-mobile.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/os-36-months.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/os-36-months-mobile.svg Greater Than Three Times Increase in Overall Survival Chart. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/efficacy/real-world-evidence 2026-10-07 https://www.tibsovopro.com/static/images/vs-efficacy-bar-chart-1.svg Bar graph showing CR and CRi/p for TIBSOVO + AZA (41% CR and 63% CR + CRi/p) compared against VEN + HMA (27% CR and 50% CR + CRi/p). https://www.tibsovopro.com/static/images/vs-efficacy-bar-chart-2.svg Bar graph showing 6-month EFS rate for TIBSOVO + AZA (55%) compared to VEN + HMA (40%). https://www.tibsovopro.com/static/images/vs-efficacy-bar-chart-3.svg Bar graph showing rate of patients proceeding to allogeneic stem cell transplant for TIBSOVO + AZA (12%) compared to VEN + HMA (5%). https://www.tibsovopro.com/aml/efficacy/newly-diagnosed 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/efficacy/relapsed-refractory 2026-09-11 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/safety 2026-09-11 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/dosing-and-management 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/ivosidenib-tablets.png Ivosidenib Tablets. https://www.tibsovopro.com/static/images/tibsovo-dosing-and-management-guide.png TIBSOVO Dosing and Management Guide. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/idh1-and-tibsovo 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/aml/patient-profiles 2026-10-15 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier logo. https://www.tibsovopro.com/static/images/patient-profiles/michael-card.png Michael - hypothetical case. https://www.tibsovopro.com/static/images/patient-profiles/margaret-photo.jpg Margaret - hypothetical case. https://www.tibsovopro.com/static/images/patient-profiles/eleanor-photo.jpg Eleanor - hypothetical case. https://www.tibsovopro.com/static/images/patient-profiles/phil-photo.png Phil - hypothetical case. https://www.tibsovopro.com/aml/access 2026-09-16 https://www.tibsovopro.com/static/images/bottle-of-tibsovo-ivosidenib-tablets.png TIBSOVO® (ivosidenib tablets) bottle with two pills. https://www.tibsovopro.com/static/images/servier-one-logo.svg ServierONE Logo. https://www.tibsovopro.com/aml/faqs-resources 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/tibsovo-prescribing-information.png TIBSOVO® Prescribing Information. https://www.tibsovopro.com/static/images/tibsovo-dosing-and-management-guide.png TIBSOVO® Dosing and Management Guide. https://www.tibsovopro.com/static/images/tibsovo-plus-azacitidine-brochure.png TIBSOVO® + Azacitidine Brochure. https://www.tibsovopro.com/static/images/tibsovo-plus-azacitidine-long-term-data-brochure.png TIBSOVO® + Azacitidine Long-term Data Brochure. https://www.tibsovopro.com/static/images/tibsovo-patient-brochure-for-aml.png TIBSOVO® Patient Brochure for AML. https://www.tibsovopro.com/static/images/tibsovo-medication-guide.png TIBSOVO® Medication Guide. https://www.tibsovopro.com/static/images/differentiation-syndrome-reference-card.png Differentiation Syndrome Reference Card. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/number-one-rescribed-midh1-inhibitor.png Number One Prescribed mIDH1 Inhibitor. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/site-map 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/efficacy 2026-10-07 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/sixty-seven-percent-mds-icon.svg Transfusion independence in patients (6/9) who were transfusion-dependent at baseline. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/safety 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/dosing-and-management 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/ivosidenib-tablets.png Ivosidenib Tablets. https://www.tibsovopro.com/static/images/tibsovo-dosing-and-management-guide.png TIBSOVO® Dosing and Management Guide. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/idh1-and-mds 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/mds-aml-evolution 2026-09-14 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/access 2026-09-16 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/bottle-of-tibsovo-ivosidenib-tablets.png TIBSOVO® (ivosidenib tablets) bottle with two pills. https://www.tibsovopro.com/static/images/servier-one-logo.svg ServierONE Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/mds/faqs-resources 2026-10-07 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/tibsovo-prescribing-information.png TIBSOVO® Prescribing Information. https://www.tibsovopro.com/static/images/mds-brochure.png MDS Brochure. https://www.tibsovopro.com/static/images/tibsovo-dosing-and-management-guide.png TIBSOVO® Dosing and Management Guide. https://www.tibsovopro.com/static/images/tibsovo-mds-efficacy-brochure.png TIBSOVO® MDS Efficacy Brochure. https://www.tibsovopro.com/static/images/tibsovo-patient-brochure-for-mds.png TIBSOVO® Patient Brochure for MDS. https://www.tibsovopro.com/static/images/tibsovo-medication-guide.png TIBSOVO® Medication Guide. https://www.tibsovopro.com/static/images/differentiation-syndrome-reference-card.png Differentiation Syndrome Reference Card. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca 2026-09-17 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/cca-bottle-with-2-pills.png TIBSOVO® (ivosidenib tablets) bottle with two tablets. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/site-map 2026-09-17 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/efficacy 2026-10-09 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/cca-chart-efficacy-1.png CCA Efficacy chart. https://www.tibsovopro.com/static/images/cca-chart-efficacy-mobile-1.png CCA Efficacy chart. https://www.tibsovopro.com/static/images/cca-chart-1.svg Chart of treatment duration. https://www.tibsovopro.com/static/images/cca-chart-mobile-1_new.png Chart of treatment duration. https://www.tibsovopro.com/static/images/cca-chart-2.svg Chart of all patients treated with placebo, including those crossed over to Tibsovo. https://www.tibsovopro.com/static/images/cca-chart-mobile-2_new.png Chart of all patients treated with placebo, including those crossed over to Tibsovo. https://www.tibsovopro.com/static/images/cca-chart-efficacy-2_new.png Graph of overall survival comparing Tibsovo with placebo. https://www.tibsovopro.com/static/images/cca-chart-mobile-3.png Graph of overall survival comparing Tibsovo with placebo. https://www.tibsovopro.com/static/images/cca-chart-4.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/functional-subscales.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/cca-chart-5.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/icon-QLC-C30.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/cca-chart-6.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/icon-QLQ-BIL21.svg Graph showing health-related quality of life (QoL). https://www.tibsovopro.com/static/images/cca-modal-1.svg Key eligibility criteria for the ClarIDHy trial. https://www.tibsovopro.com/static/images/cca-modal-mobile-1_new.svg Study Design. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/safety 2026-09-17 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/dosing-and-management 2026-09-17 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/ivosidenib-tablets.png Ivosidenib Tablets. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/idh1-and-cca 2026-10-09 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/idh1-cca-table.png Graph showing age-adjusted incidence of CCA by subtype - Total CCA, extrahepatic and intrahepatic. https://www.tibsovopro.com/static/images/idh1-cca-table-mobile_new.png Graph showing age-adjusted incidence of CCA by subtype - Total CCA, extrahepatic and intrahepatic. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/access 2026-09-17 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-one-logo.svg ServierONE Logo. https://www.tibsovopro.com/static/images/bottle-of-tibsovo-ivosidenib-tablets.png TIBSOVO® (ivosidenib tablets) bottle with two pills. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/cca/faqs-resources 2026-09-18 https://www.tibsovopro.com/static/images/tibsovo-logo.svg TIBSOVO® (ivosidenib tablets) Logo. https://www.tibsovopro.com/static/images/servier-logo.svg Servier Logo. https://www.tibsovopro.com/static/images/tibsovo-cca-prescribing-information.png TIBSOVO® Prescribing Information. https://www.tibsovopro.com/static/images/tibsovo-cca-product-guide.png TIBSOVO® Product Guide. https://www.tibsovopro.com/static/images/tibsovo-cca-flashcard.png TIBSOVO® CCA Flashcard. https://www.tibsovopro.com/static/images/tibsovo-cca-patient-brochure.png TIBSOVO® Patient Brochure. https://www.tibsovopro.com/static/images/tibsovo-cca-medication-guide.png TIBSOVO® Medication Guide. https://www.tibsovopro.com/static/images/clarIDHy-trial-leave-behind.png The ClarIDHy Trial Leave Behind.